Riskpilot← Back to searchSign inGet full accessINTERMEDICO LTD. ApS
APSActiveCVR 26172578Viadukt Alle 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20011 employeeswww.intermedico.dk
Revenue 2025
DKK 266K
+33% vs 2024
EBITDA margin
37.4%
+122% vs 2024
Equity ratio
15.2%
Financial strength
Net profit 2025
DKK 57K
+1498% vs 2024
| Revenue | DKK 266K | +33% |
| EBITDA | DKK 100K | +122% |
| Net profit | DKK 57K | +1498% |
| Total assets | DKK 2M | -3% |
| Equity | DKK 307K | +23% |
| Employees | 1 | — |
Legal name
INTERMEDICO LTD. ApS
CVR number
26172578
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. august 2001
Share capital
DKK 450.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive handel, håndværk, industri samt anden dermed i forbindelse stående virksomhed.
Address
Viadukt Alle 16
Phone
+4529739360
Email
pa@intermedico.dk
Website
www.intermedico.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 568 | 631 | 487 | 456 | 501 | 462 | 395 | 306 | 449 | 489 | 114 | 217 | 200 | 266 |
| Staff expenses | -474 | -436 | -440 | -420 | -423 | -371 | -353 | -208 | -385 | -464 | -427 | -220 | -156 | -167 |
| EBITDA | 94 | 195 | 46 | 37 | 78 | 91 | 42 | 98 | 65 | 25 | -313 | -3 | 45 | 100 |
| Depreciation & amort. | -86 | -76 | -80 | -78 | -2 | -34 | -34 | -40 | -4 | -4 | -4 | -4 | -4 | -4 |
| EBIT | 7 | 120 | -34 | -41 | 77 | 57 | 9 | 58 | 61 | 21 | -317 | -7 | 41 | 96 |
| Net financials | -1 | 20 | -10 | -28 | -48 | -33 | -36 | -37 | -15 | 5 | -43 | -39 | -46 | -22 |
| Profit before tax | 7 | 140 | -44 | -70 | 29 | 24 | -28 | 21 | 45 | 26 | -359 | -46 | -5 | 74 |
| Tax | 3 | 38 | -12 | 2 | -38 | 37 | -6 | 5 | 10 | 6 | -79 | -9 | -1 | 16 |
| Net profit | 4 | 102 | -32 | -72 | 67 | -13 | -22 | 16 | 35 | 20 | -280 | -37 | -4 | 57 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.130 | 1.513 | 1.382 | 1.164 | 1.416 | 1.379 | 1.577 | 1.627 | 1.783 | 2.152 | 1.955 | 2.073 | 2.085 | 2.016 |
| Equity | 468 | 570 | 538 | 466 | 534 | 521 | 499 | 515 | 550 | 571 | 290 | 253 | 249 | 307 |
| Long-term debt | 155 | 302 | 190 | 135 | 202 | 164 | 108 | 0 | 0 | 147 | 51 | 0 | 0 | 0 |
| Short-term debt | 499 | 630 | 654 | 562 | 680 | 694 | 970 | 1.112 | 1.227 | 1.427 | 1.614 | 1.820 | 1.835 | 1.709 |
| Total debt | 654 | 931 | 844 | 697 | 882 | 858 | 1.078 | 1.112 | 1.227 | 1.574 | 1.665 | 1.820 | 1.835 | 1.709 |
EBITDA margin
37.4%
This company
15.8%
Market median
+137% vs market
20122025
Equity ratio
15.2%
This company
38.2%
Market median
-60% vs market
20122025
Return on equity
18.6%
This company
18.4%
Market median
+1% vs market
20122025
Net profit margin
21.4%
This company
8.1%
Market median
+164% vs market
20122025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20122025
Debt / equity
5.58×
This company
0.62×
Market median
-800% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AM | Audit | 2001 | — | — |
PA Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
SB Management | Management | 2001 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
VIADUKT ANPARTSSELSKAB 260954 | Company | 100.0% | 100.0% | 2001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VIADUKT ANPARTSSELSKAB 260954
INTERMEDICO LTD. ApS Board members of INTERMEDICO LTD. ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alex Michael Ankjær-Jensen | Audit | 0 companies |
| Preben Arnfjord | Chief Executive Officer | 0 companies |
| Sten Brincker | Management | 0 companies |